search
Back to results

Study to Assess Tolerance of Traces in Peanut/Tree Nut Allergic Children.

Primary Purpose

Food Allergy, Peanut Allergy, Tree Nut Allergy

Status
Recruiting
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Oral food challenge to foods with traces
Sponsored by
University Hospital, Geneva
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Food Allergy focused on measuring Peanut allergy, Tree Nut allergy, Precautionary allergen labeling, May contain traces, Allergen threshold

Eligibility Criteria

2 Years - 18 Years (Child, Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Children aged 2-18 years at time of inclusion
  • Tree nut or peanut allergy documented by:

    • Positive skin prick tests (SPTs) to peanut and/or tree nuts
    • Positive specific IgE (sIgE) to peanut and/or tree nuts ( ≥0.35 kU/L)
    • A recent (< 1 year) positive food challenge, reacting to the dose of 30 mg of proteins or below.
  • Parent/Legal guardian has been informed about the study and has signed Informed Consent Form

Exclusion Criteria:

  • History of a moderate or severe reaction during a food challenge with a dose of 30 mg of proteins or less.
  • Expected non-adherence to the study protocol.
  • Severe or uncontrolled asthma.

Sites / Locations

  • Pediatric Allergy Unit - University Hospitals of GenevaRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Foods with traces

Arm Description

Oral food challenge with foods with traces

Outcomes

Primary Outcome Measures

Result of the food challenges with foods labelled with "may contain traces" (tolerated or reacted).
Result of the food challenges with foods labelled with "may contain traces" (tolerated or reacted).

Secondary Outcome Measures

Tolerance to foods labelled with "may contain traces" eaten normally during a 3 months follow-up.
Tolerance to foods labelled with "may contain traces" eaten normally during a 3 months follow-up (reactions / no reactions to these foods).
Frequency of reactions to foods labelled with "may contain traces" eaten normally during a 3 months follow-up.
Frequency of reactions to foods labelled with "may contain traces" eaten normally during a 3 months follow-up (number of reactions).
Severity of reactions to foods labelled with "may contain traces" eaten normally during a 3 months follow-up.
Severity of reactions to foods labelled with "may contain traces" eaten normally during a 3 months follow-up (severity of reactions by reaction type).
Changes of quality of life after 3 months without restriction of foods labelled with "may contain traces", compared to baseline when restricting.
Changes of quality of life measured with the age-appropriate "Food allergy quality of life questionnaire (0-12 years [parents], 7-12 years [patients], or 13-17 years [patients]. Results (on a continuous numerical ranking from 1 to 6 for each item) after 3 months without restriction of foods labelled with "may contain traces", are compared to baseline when restricting.

Full Information

First Posted
July 25, 2018
Last Updated
May 18, 2022
Sponsor
University Hospital, Geneva
search

1. Study Identification

Unique Protocol Identification Number
NCT03680066
Brief Title
Study to Assess Tolerance of Traces in Peanut/Tree Nut Allergic Children.
Official Title
Assessing Tolerance to "May Contain Traces" Processed Foods in Tree Nuts or Peanut Allergic Children.
Study Type
Interventional

2. Study Status

Record Verification Date
May 2022
Overall Recruitment Status
Recruiting
Study Start Date
April 1, 2018 (Actual)
Primary Completion Date
December 2023 (Anticipated)
Study Completion Date
December 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Hospital, Geneva

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This protocol will help better define whether patients with peanut and/or tree nut food allergy can tolerate traces in products with precautionary allergen labelling.
Detailed Description
Visit 1 (V1): During this visit at the Pediatric Research Platform at the Children's Hospital, subjects will undergo an open food challenge to 3 processed foods labeled with "may contain traces" by following safety and accuracy guidelines for food challenges (7). The following foods (similar for all patients) will be given in one dose in the size of a regular serving: cookies, max 30 g; chocolate, max 30 g; breakfast cereals, max 50 g. Each meal will be administered with a 1 hour observation period in between and at the end. If the patient does not react to any of the foods or has only oral itching (mild symptoms), he/she will be instructed to stop the ban on "may contain" foods and eat them regularly. If the patient has more than mild symptoms, the study will be stopped and the patient will be banned from eating foods with traces. The study subjects with a negative challenge and instructed to eat foods with the "may contain" label will be provided emergency medications and instruction on when and how to use them according to current guidelines (8). An age appropriate quality of life questionnaire will be filled out by the parents/patient during the visit. For the following 3 months after "may contain food" challenges, the patients will be invited to eat on a regular basis any foods labeled as "may contain" tree nuts and/or peanuts and record the consumption on a diary. Such foods will only be eaten in presence of a family member instructed for the measures to be taken in case of a reaction. They will record any history of reaction and contact the study team. The brand name of the food, and if available the batch will be recorded. The participants will store the study food and its packaging safely in a box and bring it along at V2 for allergen content analysis. If a reaction occurs, the food will be analyzed for allergen content by immunoaffinity capillary elecrophoresis-matrix assisted laser desorption/ionization mass spectrometry, as well as a simplified version of this technique, the immunomagnetic separation -matrix-assisted laser desorption/ionization mass spectrometry. Visit 2 (V2): During this visit, the parents/patients will report on the brand, the frequency and the amount of "may contain" foods eaten since V1. The quality of life questionnaire will be filled out again by the parents/patient.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Food Allergy, Peanut Allergy, Tree Nut Allergy
Keywords
Peanut allergy, Tree Nut allergy, Precautionary allergen labeling, May contain traces, Allergen threshold

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
35 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Foods with traces
Arm Type
Experimental
Arm Description
Oral food challenge with foods with traces
Intervention Type
Other
Intervention Name(s)
Oral food challenge to foods with traces
Intervention Description
Subjects will undergo an open food challenge to 3 processed foods labeled with "may contain traces". The following foods (similar for all patients) will be given in one dose in the size of a regular serving: cookies, max 30 g; chocolate, max 30 g; breakfast cereals, max 50 g. Each meal will be administered with a 1 hour observation period in between and at the end.
Primary Outcome Measure Information:
Title
Result of the food challenges with foods labelled with "may contain traces" (tolerated or reacted).
Description
Result of the food challenges with foods labelled with "may contain traces" (tolerated or reacted).
Time Frame
At study entry
Secondary Outcome Measure Information:
Title
Tolerance to foods labelled with "may contain traces" eaten normally during a 3 months follow-up.
Description
Tolerance to foods labelled with "may contain traces" eaten normally during a 3 months follow-up (reactions / no reactions to these foods).
Time Frame
During 3 months follow-up
Title
Frequency of reactions to foods labelled with "may contain traces" eaten normally during a 3 months follow-up.
Description
Frequency of reactions to foods labelled with "may contain traces" eaten normally during a 3 months follow-up (number of reactions).
Time Frame
During 3 months follow-up
Title
Severity of reactions to foods labelled with "may contain traces" eaten normally during a 3 months follow-up.
Description
Severity of reactions to foods labelled with "may contain traces" eaten normally during a 3 months follow-up (severity of reactions by reaction type).
Time Frame
During 3 months follow-up
Title
Changes of quality of life after 3 months without restriction of foods labelled with "may contain traces", compared to baseline when restricting.
Description
Changes of quality of life measured with the age-appropriate "Food allergy quality of life questionnaire (0-12 years [parents], 7-12 years [patients], or 13-17 years [patients]. Results (on a continuous numerical ranking from 1 to 6 for each item) after 3 months without restriction of foods labelled with "may contain traces", are compared to baseline when restricting.
Time Frame
At entry and after 3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
2 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Children aged 2-18 years at time of inclusion Tree nut or peanut allergy documented by: Positive skin prick tests (SPTs) to peanut and/or tree nuts Positive specific IgE (sIgE) to peanut and/or tree nuts ( ≥0.35 kU/L) A recent (< 1 year) positive food challenge, reacting to the dose of 30 mg of proteins or below. Parent/Legal guardian has been informed about the study and has signed Informed Consent Form Exclusion Criteria: History of a moderate or severe reaction during a food challenge with a dose of 30 mg of proteins or less. Expected non-adherence to the study protocol. Severe or uncontrolled asthma.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
François Graham, MD, MSc
Phone
079 55 35215
Email
francois.graham@hcuge.ch
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Philippe Eigenmann, MD
Organizational Affiliation
University Hospitals of Geneva
Official's Role
Principal Investigator
Facility Information:
Facility Name
Pediatric Allergy Unit - University Hospitals of Geneva
City
Geneva
ZIP/Postal Code
1205
Country
Switzerland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
François Graham, MD, MSc
Email
francois.graham@hcuge.ch

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Study to Assess Tolerance of Traces in Peanut/Tree Nut Allergic Children.

We'll reach out to this number within 24 hrs